Pre-training Catechin gavage prevents memory impairment induced by intracerebroventricular streptozotocin in rats

References

1. ↵
   1. Weiner MW,
   2. Veitch DP,
   3. Aisen PS,
   4. Beckett LA,
   5. Cairns NJ,
   6. Green RC,
   7. et al.

   (2012) The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 8, S1–S68.
2. ↵
   1. Mayeux R

   (2010) Clinical practice. Early Alzheimer's disease. N Engl J Med 362, 2194–2201.
3. ↵
   1. Braak H,
   2. Braak E,
   3. Bohl J,
   4. Bratzke H

   (1998) Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl 54, 97–106.
4. ↵
   1. Butterfield DA,
   2. Reed T,
   3. Newman SF,
   4. Sultana R

   (2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43, 658–677.
5. ↵
   1. Zhu X,
   2. Lee HG,
   3. Perry G,
   4. Smith MA

   (2007) Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 1772, 494–502.
6. ↵
   1. Nunomura A,
   2. Perry G,
   3. Aliev G,
   4. Hirai K,
   5. Takeda A,
   6. Balraj EK,
   7. et al.

   (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759–767.
7. ↵
   1. Nunomura A,
   2. Perry G,
   3. Pappolla MA,
   4. Friedland RP,
   5. Hirai K,
   6. Chiba S,
   7. et al.

   (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59, 1011–1017.
8. ↵
   1. Praticò D,
   2. Uryu K,
   3. Leight S,
   4. Trojanoswki JQ,
   5. Lee VM

   (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21, 4183–4187.
9. ↵
   1. Smith MA,
   2. Hirai K,
   3. Hsiao K,
   4. Pappolla MA,
   5. Harris PL,
   6. Siedlak SL,
   7. et al.

   (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70, 2212–2215.
10. ↵
    1. Hayashi T,
    2. Shishido N,
    3. Nakayama K,
    4. Nunomura A,
    5. Smith MA,
    6. Perry G,
    7. et al.

    (2007) Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic Biol Med 43, 1552–1559.
11. ↵
    1. Ye X,
    2. Tai W,
    3. Zhang D

    (2012) The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits. Neurobiol Aging 33, 1122.
12. ↵
    1. Wang X,
    2. Su B,
    3. Siedlak SL,
    4. Moreira PI,
    5. Fujioka H,
    6. Wang Y,
    7. et al.

    (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105, 19318–19323.
13. ↵
    1. Lee HG,
    2. Casadesus G,
    3. Zhu X,
    4. Takeda A,
    5. Perry G,
    6. Smith MA

    (2004) Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci 1019, 1–4.
14. ↵
    1. Weinreb O,
    2. Mandel S,
    3. Amit T,
    4. Youdim MB

    (2004) Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem 15, 506–516.
15. ↵
    1. Nanjo F,
    2. Goto K,
    3. Seto R,
    4. Suzuki M,
    5. Sakai M,
    6. Hara Y

    (1996) Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radic Biol Med 21, 895–902.
16. ↵
    1. Pan MH,
    2. Lin-Shiau SY,
    3. Ho CT,
    4. Lin JH,
    5. Lin JK

    (2000) Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3’-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol 59, 357–367.
17. ↵
    1. Nobre Júnior HV,
    2. Cunha GM,
    3. Maia FD,
    4. Oliveira RA,
    5. Moraes MO,
    6. Rao VS

    (2003) Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. Comp Biochem Physiol C Toxicol Pharmacol 136, 175–180.
18. ↵
    1. Levites Y,
    2. Amit T,
    3. Mandel S,
    4. Youdim MB

    (2003) Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 17, 952–954.
19. ↵
    1. Levites Y,
    2. Weinreb O,
    3. Maor G,
    4. Youdim MB,
    5. Mandel S

    (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78, 1073–1082.
20. ↵
    1. Levites Y,
    2. Youdim MB,
    3. Maor G,
    4. Mandel S

    (2002) Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63, 21–29.
21. ↵
    1. Behl C,
    2. Davis J,
    3. Cole GM,
    4. Schubert D

    (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186, 944–950.
22. ↵
    1. Choi DY,
    2. Lee YJ,
    3. Hong JT,
    4. Lee HJ

    (2012) Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Res Bull 87, 144–153.
23. ↵
    1. Paxinos G,
    2. Watson C

    , eds (1986) The rat brain in stereotaxic coordinates (Academic Press, New York (NY)).
24. ↵
    1. Parvez S,
    2. Tabassum H,
    3. Rehman H,
    4. Banerjee BD,
    5. Athar M,
    6. Raisuddin S

    (2006) Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice. Toxicology 225, 109–118.
25. ↵
    1. Babri S,
    2. Badie HG,
    3. Khamenei S,
    4. Seyedlar MO

    (2007) Intrahippocampal insulin improves memory in a passive-avoidance task in male wistar rats. Brain Cogn 64, 86–91.
26. ↵
    1. Hoyer S

    (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490, 115–125.
27. ↵
    1. Lannert H,
    2. Hoyer S

    (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112, 1199–1208.
28. ↵
    1. Agrawal R,
    2. Tyagi E,
    3. Shukla R,
    4. Nath C

    (2011) Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur Neuropsychopharmacol 21, 261–273.
29. ↵
    1. Ho L,
    2. Qin W,
    3. Pompl PN,
    4. Xiang Z,
    5. Wang J,
    6. Zhao Z,
    7. et al.

    (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18, 902–904.
30. ↵
    1. Cheng CM,
    2. Tseng V,
    3. Wang J,
    4. Wang D,
    5. Matyakhina L,
    6. Bondy CA

    (2005) Tau is hyperphosphorylated in the insulin-like growth factor-I null brain. Endocrinology 146, 5086–5091.
31. ↵
    1. Li Q,
    2. Zhao HF,
    3. Zhang ZF,
    4. Liu ZG,
    5. Pei XR,
    6. Wang JB,
    7. et al.

    (2009) Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience 163, 741–749.
32. ↵
    1. Butterfield DA,
    2. Boyd-Kimball D

    (2005) The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703, 149–156.
33. ↵
    1. Watanabe H,
    2. Kobayashi A,
    3. Yamamoto T,
    4. Suzuki S,
    5. Hayashi H,
    6. Yamazaki N

    (1990) Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Radic Biol Med 8, 507–514.
34. ↵
    1. Zhang L,
    2. Zhao B,
    3. Yew DT,
    4. Kusiak JW,
    5. Roth GS

    (1997) Processing of Alzheimer's amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells. Biochem Biophys Res Commun 235, 845–848.
35. ↵
    1. Cuevas E,
    2. Limón D,
    3. Pérez-Severiano F,
    4. Díaz A,
    5. Ortega L,
    6. Zenteno E,
    7. et al.

    (2009) Antioxidant effects of epicatechin on the hippocampal toxicity caused by amyloid-beta 25-35 in rats. Eur J Pharmacol 616, 122–127.
36. ↵
    1. Tournaire C,
    2. Croux S,
    3. Maurette MT,
    4. Beck I,
    5. Hocquaux M,
    6. Braun AM,
    7. et al.

    (1993) Antioxidant activity of flavonoids: efficiency of singlet oxygen (1 delta g) quenching. J Photochem Photobiol B 19, 205–215.
37. ↵
    1. Khan SG,
    2. Katiyar SK,
    3. Agarwal R,
    4. Mukhtar H

    (1992) Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res 52, 4050–4052.
38. ↵
    1. Kimura M,
    2. Umegaki K,
    3. Kasuya Y,
    4. Sugisawa A,
    5. Higuchi M

    (2002) The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 56, 1186–1193.